Free Trial

IGM Biosciences (IGMS) Earnings Date, Estimates & Call Transcripts

IGM Biosciences logo
$1.27 0.00 (0.00%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$1.27 +0.00 (+0.39%)
As of 08/8/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IGM Biosciences Earnings Summary

IGM Biosciences announced Q2 2025 earnings on July 31, 2025, reporting an EPS of $1.58, which topped the consensus estimate of -$0.30 by $1.88. Quarterly revenue was reported to be $143.62 million, above analysts' expectations of $3.20 million. With a trailing EPS of -$0.90, IGM Biosciences' earnings are expected to grow next year, from ($3.35) to ($0.96) per share.

Upcoming Q3
Earnings Date
Aug. 13Before Market OpensEstimated
Consensus EPS
(Jul. 31)
-$0.30
Actual EPS
(Jul. 31)
$1.58 Beat By $1.88
Actual Revenue
(Jul. 31)
$143.62M

Q2 2025 Earnings Resources

IGMS Upcoming Earnings

IGM Biosciences' Q2 2025 earnings is scheduled for Wednesday, August 13, 2025

Get IGM Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IGM Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

IGMS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IGMS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IGM Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.85-$0.46-$0.66
Q2 20252-$0.88-$0.38-$0.63
Q3 20252-$0.90-$0.40-$0.65
Q4 20252-$0.93-$0.40-$0.67

IGM Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/13/2025
(Estimated)
--------
7/31/2025Q2 2025-$0.30$1.58+$1.88$1.58$3.20M$143.62M
5/13/2025Q1 2025-$0.41-$0.86 -$0.45-$0.86$4.25M$0.50M
3/6/2025Q4 2024-$0.74-$0.61+$0.13-$0.61$0.39M$0.41M
11/8/2024--$0.82-$1.01 -$0.19-$1.01$0.23M$0.52M
8/14/2024-$0.18-$0.79 -$0.97-$0.79$51.75M$1.25M
5/8/2024Q1 2024-$0.84-$0.83+$0.01-$0.83$0.71M$0.50M
3/7/2024Q4 2023-$1.06-$1.01+$0.05-$1.01$0.95M$0.65M
11/13/2023Q3 2023-$1.25-$1.04+$0.21-$1.04$0.73M$0.51M

IGM Biosciences Earnings - Frequently Asked Questions

IGM Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on IGMS's earnings history.

In the previous quarter, IGM Biosciences (NASDAQ:IGMS) reported $1.58 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $1.88. Learn more on analysts' earnings estimate vs. IGMS's actual earnings.

IGM Biosciences (NASDAQ:IGMS) has a recorded annual revenue of $2.68 million.

IGM Biosciences (NASDAQ:IGMS) has a recorded net income of -$195.79 million. IGMS has generated -$0.90 earnings per share over the last four quarters.

IGM Biosciences' earnings are expected to grow from ($3.35) per share to ($0.96) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:IGMS) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners